Lumexa Imaging Q3 revenue rises, swings to net profit
LMRI•Lumexa Imaging reported Q3 revenue of $272 million, adjusted EPS of $0.26 and net income of $7.20 million. It raised 2026 adjusted EPS guidance to $0.86-$0.90 and narrowed adjusted EBITDA guidance to $236 million-$240 million, while reiterating revenue guidance of $1.045 billion-$1.097 billion.
1. Q3 results
Lumexa Imaging reported Q3 revenue of $272 million, adjusted EPS of $0.26, EPS of $0.07, net income of $7.20 million and adjusted EBITDA of $62.60 million. The company had posted a net loss a year earlier.
2. 2026 guidance
The company reiterated full-year revenue guidance of $1.045 billion to $1.097 billion, narrowed adjusted EBITDA guidance to $236 million-$240 million with the midpoint unchanged, and raised adjusted EPS guidance to $0.86-$0.90 from $0.71-$0.77. Lumexa Imaging said advanced modalities reached a record-high share of Q3 volumes.
